Enzon Pharmaceuticals, Inc. receives royalty revenues from existing licensing arrangements with other companies primarily related to sales of four marketed drug products, namely, PegIntron R , Sylatron R , Macugen R and CIMZIA R .
Quote | Enzon Pharmaceuticals Inc (OTCMKTS:ENZN)
Last: | $0.0945 |
---|---|
Change Percent: | -11.83% |
Open: | $0.0945 |
Close: | $0.0945 |
High: | $0.0945 |
Low: | $0.0945 |
Volume: | 147 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Enzon Pharmaceuticals Inc (OTCMKTS:ENZN)
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
Message Board Posts | Enzon Pharmaceuticals Inc (OTCMKTS:ENZN)
Subject | By | Source | When |
---|---|---|---|
Dang I didnt even realize that till you | aquaspin | investorshub | 01/11/2023 1:50:10 AM |
$ENZN 1/4 Million shares on the bid @ | jjp2516 | investorshub | 01/10/2023 10:28:05 PM |
$ENZN Huge potential. Just a matter of time. | aquaspin | investorshub | 11/30/2022 4:11:33 AM |
ENZN .265 on watch | Longer Than Most | investorshub | 11/28/2022 3:18:34 PM |
Cmon Carl lets get this Party started | jjp2516 | investorshub | 08/08/2022 7:33:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Enzon Pharmaceuticals Inc Company Name:
ENZN Stock Symbol:
OTCMKTS Market:
Enzon Pharmaceuticals Inc Website:
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...